Analog Devices, Inc. vs Align Technology, Inc. — how do they compare? Analog Devices, Inc. trades at $396.99 (market cap $187.67B), while Align Technology, Inc. trades at $172.77 (market cap $12.29B). The key difference: Analog Devices, Inc. is far larger — about 15.3× Align Technology, Inc.'s market cap, and Analog Devices, Inc. pays a 1.14% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ADI | ALGN | |
|---|---|---|
Market Cap | $187.67B | $12.29B |
Sector | Technology | Health |
52-Week High | $445.48 | $197.51 |
52-Week Low | $225.20 | $124.88 |
Enterprise Value | $192.92B | $11.30B |
Dividend Yield | 1.14% | — |
Signals from Pluang's Aura AI — not financial advice
Analog Devices (ADI) trades at $383.93, down 1.54% on the day, with a bullish technical signal from moving averages. The company demonstrates strong profitability with a 26.01% net income margin and has beaten earnings estimates for the last three quarters. Recent news highlights institutional buying and a spin-off of ADI Global Distribution, completed August 4, 2026, as per a Business Wire report.
The outlook is positive, supported by a strong analyst consensus with a $472.29 price target and no sell ratings. Key opportunities include consistent earnings outperformance and exposure to semiconductor sector growth. Risks involve high valuation multiples and potential market volatility impacting the stock's premium pricing.
No Aura AI signal available yet.
Trailing returns across standard periods
Analog Devices is a leading analog, mixed signal, and digital signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers, and more than half of its chip sales are made to industrial and automotive end markets. Analog Devices' chips are also incorporated into wireless infrastructure equipment.
Read more on ADI →Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →